000			02259nam a2200469 i 4500
001			EBC4815063
003			MiAaPQ
005			20240121111425.0
006			m o d |
007			cr cnu||||||||
008			161223s2017 enkad ob 001 0 eng|d
020			_z9781119289746 (pbk.)
020			_z9781119289746
020			_a9781119289753 _q(electronic bk.)
020			_a9781119289753 _q(electronic bk.)
035			_a(MiAaPQ)EBC4815063
035			_a(Au-PeEL)EBL4815063
035			_a(CaPaEBR)ebr11354742
035			_a(OCoLC)973222751
040			_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ
050		4	_aRM302.5 _b.W35 2017
082	0		_a615/.7042 _223
100	1		_aWaller, Patrick, _d1957 January 30- _eauthor.
245	1	3	_aAn introduction to pharmacovigilance / _cPatrick Waller, Mira Harrison-Woolrych.
250			_aSecond edition.
264		1	_aChichester, West Sussex, UK ; _aHoboken, NJ : _bJohn Wiley & Sons Incorporated, _c2017.
300			_a1 online resource (193 pages) : _billustrations
336			_atext _2rdacontent
337			_acomputer _2rdamedia
338			_aonline resource _2rdacarrier
504			_aIncludes bibliographical references and index.
505	0		_aWhat is pharmacovigilance and how has it developed? -- Basic concepts -- Types and sources of data -- The process of pharmacovigilance -- Regulatory aspects of pharmacovigilance -- International collaboration -- Clinical aspects of adverse drug reactions -- Ethical and societal considerations -- Future directions -- Learning more about pharmacovigilance.
588			_aDescription based on print version record.
590			_aElectronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650		0	_aDrug monitoring.
650		0	_aDrugs _xSide effects.
655		4	_aElectronic books.
700	1		_aHarrison-Woolrych, Mira, _eauthor.
776	0	8	_iPrint version: _aWaller, Patrick. _tIntroduction to pharmacovigilance. _dChichester, West Sussex, UK : John Wiley & Sons Incorporated, 2017 _z9781119289746 _w(DNLM)101697888
797	2		_aProQuest (Firm)
856	4	0	_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=4815063 _zClick to View
999			_c283157 _d283157